HeraMED Limited (ASX:HMD)

Market Cap	40.09M +128.9%
Revenue (ttm)	322.93K -34.0%
Net Income	-4.53M
EPS	-0.01
Shares Out	1.11B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	320,112
Average Volume	432,193
Open	0.0360
Previous Close	0.0360
Day's Range	0.0360 - 0.0360
52-Week Range	0.0060 - 0.0490
Beta	0.73
RSI	40.09
Earnings Date	Feb 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant moth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HMD

Financial Performance

In 2024, HeraMED's revenue was 364,328, a decrease of -39.90% compared to the previous year's 606,226. Losses were -5.49 million, -18.96% less than in 2023.